V. N. Belov, S. W. Hell et al.
FULL PAPER
[
15] S. Marchesini, G. Benaglia, A. Piccinotti, R. Bresciani, A.
Preti, FEBS Lett. 1998, 428, 115–117.
16] a) P. Antes, G. Schwarzmann, K. Sandhoff, Chem. Phys. Lipids
[26] a) H. Ashida, S. Hayashi, Y. Sakamoto, Y. Tsuji, K. Yamam-
oto, H. Kumagai, T. Tochikura, Biosci. Biotechnol. Biochem.
1995, 59, 2028–2032; b) M. Ito, T. Kurita, K. Kita, J. Biol.
Chem. 1995, 270, 24370–24374; c) T. Ando, S.-C. Li, M. Ito,
Y.-T. Li, J. Chromatogr. A 2005, 1078, 193–195.
[27] a) S. Neuenhofer, G. Schwarzmann, H. Egge, K. Sandhoff, Bio-
chemistry 1985, 24, 525–532; b) S. Sonnino, D. Acquotti, G.
Kirschner, A. Uguaglianza, L. Zecca, F. Rubino, G. Tettam-
anti, J. Lipid Res. 1992, 33, 1221–1226.
[
1
992, 62, 269–280; b) A. Sofer, G. Schwarzmann, A. H. Futer-
man, J. Cell Sci. 1996, 109, 2111–2119; c) T. Nakagawa, M.
Tani, K. Kita, M. Ito, J. Biochem. 1999, 126, 604–611; d) T.
Sumida, N. Sueyoshi, M. Ito, Appl. Environ. Microbiol. 2002,
6
8, 5241–5248; e) D. L. Marks, R. D. Singh, A. Choudhury,
C. L. Wheatley, R. E. Pagano, Methods 2005, 36, 186–195.
[
17] a) M. Masserini, A. Giuliani, P. Palestini, D. Acquotti, M. [28] a) J.-L. Tayot, M. Tardy, Adv. Exp. Med. Biol. 1980, 125, 471–
Pitto, V. Chigorno, G. Tettamanti, Biochemistry 1990, 29, 697–
478; b) G. Cavallo, C. Iavarone, E. Tubaro, Carbohydr. Res.
1993, 248, 251–265.
7
01; b) V. Agmon, T. Dinur, S. Cherbu, A. Dagan, S. Gatt, Exp.
Cell Res. 1991, 196, 151–157; c) A. Terzaghi, G. Tettamanti, P.
Palestini, D. Acquotti, G. Bottiroli, M. Masserini, Eur. J. Cell
Biol. 1994, 65, 172–177; d) W. L. Picking, H. Moon, H. Wu,
W. D. Picking, Biochim. Biophis. Acta 1995, 1247, 65–73.
18] a) S. Marchesini, L. Demasi, P. Cestone, A. Preti, V. Agmon,
A. Dagan, R. Navon, S. Gatt, Chem. Phys. Lipids 1994, 72,
[29] ALEXIS Biochemicals (AXXORA, Lörrach, Germany).
[30] Similar to the preparation of ethyl α-bromopalmitate (with
MeOH) and of α-bromopalmitinic acid: R. S. Sweet, F. L. Es-
tes, J. Org. Chem. 1956, 21, 1426–1429.
[31] As for nucleophilic substitution in α-bromalkanoates, but in
boiling MeOH, because the reaction in EtOH was ac-
companied by transesterification, from: A. Rosowsky, H.
Bader, W. Kohler, J. H. Freisheim, R. G. Moran, J. Med. Chem.
1988, 31, 1338–1344.
[
1
43–152; b) V. Agmon, R. Khosravi, S. Marchesini, T. Dinur,
A. Dagan, S. Gatt, R. Navon, Clin. Chim. Acta 1996, 247, 105–
20.
1
[
19] a) N. Röckendorf, S. Bade, T. R. Hirst, H. H. Gorris, A. Frey,
Bioconjugate Chem. 2007, 18, 573–578; b) N. Röckendorf, J.
Helfmann, N. Fujimoto, K. Wehry, M. Bürger, A. Frey, Proc.
SPIE-Int. Soc. Opt. Eng. 2007, 6633, 66332A/1–66332A/9.
20] a) J. G. Molotkovsky, I. I. Mikhalyov, A. B. Imbs, L. D. Ber-
gelson, Chem. Phys. Lipids 1991, 58, 199–212; b) A. M. Surin,
E. I. Astashkin, O. N. Smirnov, I. I. Mikhalyov, J. G. Molot-
kovsky, L. D. Bergelson, Biol. Membr. 1992, 9, 495–508; c)
O. N. Smirnov, A. M. Surin, E. I. Astashkin, I. I. Mikhalyov,
J. G. Molotkovsky, Biol. Membr. 1995, 12, 174–184; d) I. M.
Molotkovskaya, N. A. Zelenova, G. V. Lutsenko, A. M. Sa-
pozhnikov, I. I. Mikhalyov, J. G. Molotkovsky, Membr. Cell
Biol. 1999, 1, 783–791.
[32] Similar to the reduction of α-azidoalkanoates [in MeOH with
addition of HCl (5–6 ) in iPrOH]: Z. Gombos, J. Nyitrai, P.
Kolonits, J. Chem. Soc., Perkin Trans. 1 1989, 1915–1921.
[33] A. M. Papini, E. Nardi, F. Nuti, J. Uziel, M. Ginanneschi, M.
Chelli, A. Brandi, Eur. J. Org. Chem. 2002, 16, 2736–2741.
[34] W. Mraz, G. Schwarzmann, J. Sattler, T. Momoi, B. Seemann,
H. Wiegandt, Hoppe-SeylerЈs Z. Physiol. Chem. 1980, 361,
177–185.
[
[35] C. Hell, J. Sadomsky, Ber. Dtsch. Chem. Ges. 1891, 24, 2388–
2396.
[36] The latter route is better; it requires additional preparation of
the methyl ester 4-MeO,NH ·HCl, but avoids the use of the
2
poorly soluble acids 4-OH-N and 4-OH-Br.
3
[
21] a) X. Song, B. I. Swanson, Anal. Chem. 1999, 71, 2097–2107; [37] In spite of the excess of bis(N-succinimidyl) carbonate, the next
b) X. Song, J. Shi, B. Swanson, Anal. Biochem. 2000, 284, 35–
step of this one-pot synthesis was not accompanied by the for-
mation of undesirable by-products, and the yield of the methyl
ester 1k was increased to 91% (cf. ref.[ ).
4
1; c) A. V. Samsonov, I. Mihalyov, F. S. Cohen, Biophys. J.
24a]
2001, 81, 1486–1500; d) X. Song, J. Shi, J. Nolan, B. Swanson,
Anal. Biochem. 2001, 291, 133–141; e) R. D. Singh, V. Puri,
J. T. Valiyaveettil, D. L. Marks, R. Bittman, R. E. Pagano, Mol.
Biol. Cell 2003, 14, 3254–3265. A number of fluorescent sphin-
golipids are now available from Invitrogen (Molecular Probes).
For gangliosides, however, the choice is limited to the BODIPY
[38] J. W. Fisher, K. L. Trinkle, Tetrahedron Lett. 1994, 35, 2505–
2508.
[39] a) S. Hünig, W. Gräßmann, V. Meuer, E. Lücke, W. Brenninger,
Chem. Ber. 1967, 100, 3039–3044; b) I. Masayasu, E. Iwao, T.
Tetsuo (Kuraray Co., Japan), Eur. Pat. Appl. 0507348
(07.10.92); c) M. A. W. Eaton, T. J. Norman, J. R. Porter
(Celltech R&D Ltd., UK), PCT Int. Appl. WO 2005 117984
(15.12.2005).
derivative linked to a C
residue: ; f) T.-Y. Wang, J. R. Silvius, Biophys. J. 2000, 79, 1478–
489; g) P. Burgos, C. Yuan, M.-L. Viriot, L. J. Johnston, Lang-
5
side chain instead of the stearic acid
1
muir 2003, 19, 8002–8009; h) L. Wawrezinieck, H. Rigneault,
D. Marguet, P.-F. Lenne, Biophys. J. 2005, 89, 4029–4042; i)
J. E. Shaw, R. F. Epand, R. M. Epand, Z. Li, R. Bittman,
C. M. Yip, Biophys. J. 2006, 90, 2170–2178; j) J. Ries, P.
Schwille, Biophys. J. 2006, 91, 1915–1924; k) J. E. Lincoln, M.
Boling, A. N. Parikh, Y. Yeh, D. G. Gilchrist, L. S. Morse, In-
vest. Ophthalmol. Vis. Sci. 2006, 47, 2172–2178.
[
40] ω-Aminostearic acid itself is known to be very poorly soluble
in most organic solvents; temporary protection of the carboxy
group improves the solubility and makes chemical transforma-
4
tions easier. However, when using aq. HClO (70%) as a cata-
lyst, we did not manage to obtain tert-butyl ω-aminostearate
directly from ω-aminostearic acid and tert-butyl acetate.
[
41] ω-Hydroxystearic acid may be synthesized in one step from the
natural kamlolenic acid (18-hydroxy-9-cis-11-trans-13-trans-oc-
tadecatrienoic acid) isolated from Mallotus philippinensis seed
oil: a) A. Gangadhar, R. Subbarao, G. Lakshminarayana, J.
Am. Oil Chem. Soc. 1987, 64, 1135–1137; b) S. C. Bhattach-
aryya, K. K. Chakravarti, U. G. Nayak, Chem. Ind. 1960, 21,
588–588; all other chemical syntheses have been reported to be
multistep: ; c) F. Riche, J.-P. Mathieu, M. Vincens, A. Bardy,
M. Comet, M. Vidal, Bull. Soc. Chim. Fr. 1984, 1–2, 49–55; d)
P. Chuit, J. Hausser, Helv. Chim. Acta 1929, 12, 463–492.
[
22] L. K. Thompson, P. M. Horowitz, K. L. Bentley, D. D.
Thomas, J. F. Alderete, R. J. Klebe, J. Biol. Chem. 1986, 261,
5
209–5214.
23] G. Schwarzmann, M. Wendeler, K. Sandhoff, Glycobiology
005, 15, 1302–1311.
[
[
2
24] A hydrophilic analogue of rhodamine Q was used: a) V. P. Bo-
yarskiy, V. N. Belov, R. Medda, B. Hein, M. Bossi, S. W. Hell,
Chem. Eur. J. 2008, 14, 1784–1792; b) commercially available
ATTO 647N (ATTO-Tec GmbH, Siegen, www.atto-tec.com)
was also used.
25] The position of the NBD label inside the lipid bilayer in phos-
phocholine and phosphoethanol amine derivatives has been
studied: a) A. Chattopadhyay, E. London, Biochemistry 1987,
[42] ω-Bromostearic acid has been obtained from ω-hydroxystearic
acid (see ref.[ ), by oxidation of ω-bromooctadecanol [a)
R. A. Sabbadini, W. A. Garland, G. Hansen (Lpath Inc.,
USA), PCT Int. Appl. WO 2007 140431 (06.12.2007)], from
octadec-17-enoic acid (b) V. G. DeVries, D. B. Moran, G. R.
Allen, S. J. Riggi, J. Med. Chem. 1976, 19, 946–957) or from
1,16-hexadecanediol (c) J. G. Pomonis, H. Hakk, Lipids 1990,
25, 821–826).
39d]
[
2
6, 39–45; b) A. Chattopadhyay, E. London, Biochim. Biophys.
Acta 1988, 938, 24–34; for a schematic diagram of half of the
membrane bilayer, see: c) A. Chattopadhyay, Chem. Phys. Lip-
ids 1990, 53, 1–15.
5176
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 5162–5177